BioCentury
ARTICLE | Clinical News

Phase II data for Bexxar

December 4, 2000 8:00 AM UTC

Coulter (CLTR) and partner SmithKline Beecham (LSE:SB; SBH) announced data from a Phase II trial of Bexxar (tositumomab iodine 131) showing that the monoclonal antibody worked in patients with non-Hod...